Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 2935-2944

  Thomas, Sarah L ^a   Oft, Martin ^b   Jaksche, Herbert ^a   Casari, Georg ^c   Heger, Peter ^d   Dobrovnik, Marika ^a   Bevec, Dorian ^a   Hauber, Joachim ^a,d  

^a NOVARTIS RESEARCH INSTITUTE   (Austria)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

REV PROTEIN; VIRUS PROTEIN;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; CIS TRANS ISOMERISM; COMPETITIVE INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; MOLECULAR INTERACTION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRANSACTIVATION; VIRUS REPLICATION;

EID: 0031924395     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.2935-2944.1998     Document Type: Article

References (111)

1. Auer, M., H.-U. Gremlich, J.-M. Seifert, T. J. Daly, T. G. Paslow, G. Casari, and H. Gstach. 1994. Helix-loop-helix motif in HIV-1 Rev. Biochem. 33:2988-2996.
2. Bahner, I., C. Zhou, X.-J. Yu, Q.-L. Hao, J. C. Guatelli, and D. B. Kohn. 1993. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. J. Virol. 67:3199-3207.
3. Bartel, D. P., M. L. Zapp, M. R. Green, and J. W. Szostak. 1991. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67:529-536.
4. Berger, J., C. Aepinus, M. Dobrovnik, B. Fleckenstein, J. Hauber, and E. Böhnlein. 1991. Mutational analysis of functional domains in the HIV-1 Rev trans-regulatory protein. Virology 183:630-635.
5. Berger, J., J. Hauber, R. Hauber, R. Geiger, and B. R. Cullen. 1988. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66:1-10.
6. Bevec, D., M. Dobrovnik, J. Hauber, and E. Böhnlein. 1992. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator. Proc Natl. Acad. Sci. USA 89:9870-9874.
7. Bevec, D., H. Jaksche, M. Oft, T. Wöhl, M. Himmelspach, A. Pacher, M. Schebesta, K. Koettnitz, M. Dobrovnik, R. Csonga, F. Lottspeich, and J. Hauber. 1996. Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science (Washington, D.C.) 271:1858-1860.
8. + T lymphocytes. Hum. Gene Ther. 5:193-201.
9. Bozerd, H., and W. C. Greene. 1993. Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. J. Virol. 67:2496-2502.
10. Bogerd, H. P., R. A. Fridell, S. Madore, and B. R. Cullen. 1995. Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82:485-494.
11. Böhnlein, E., J. Berger, and J. Hauber. 1991. Punctual mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: new insights into the domain structure of Rev and Rex. J. Virol. 65:7051-7055.
12. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
13. Chang, D. D., and P. A. Sharp. 1989. Regulation by HIV Rev depends upon recognition of splice sites. Cell 59:789-795.
14. Cochrane, A., R. Kramer, S. Ruben, J. Levine, and C. A. Rosen. 1989. The human immunodeficiency virus rev protein is a nuclear phosphoprotein. Virology 171:264-266.
15. Cochrane, A. W., K. S. Jones, S. Beidas, P. J. Dillon, A. M. Skalka, and C. A. Rosen. 1991. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J. Virol. 65:5305-5313.
16. Cochrane, A. W., A. Perkins, and C. A. Rosen. 1990. Identification of sequences important in the nucleolar localization of human immunodefidency virus Rev: relevance of nucleolar localization to function. J. Virol. 64:881-885.
17. Cole, J. L., J. D. Gehman, J. A. Shafer, and L. C. Kuo. 1993. Solution oligomerization of the Rev protein of HIV-1: implications for function. Biochemistry 32:11769-11775.
18. Cook, K. S., G. J. Fisk, J. Hauber, N. Usman, T. J. Daly, and J. R. Rusche. 1991. Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate. Nucleic Acids Res. 19:1577-1583.
19. Cullen, B. R. 1986. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 46:973-982.
20. Cullen, B. R. 1993. Does HIV-1 Tat induce a change in viral initiation rights? Cell 73:417-420.
21. Cullen, B. R. 1994. The role of Nef in the replication cycle of the human and simian immunodeficiency viruses. Virology 205:1-6.
22. Cullen, B. R., J. Hauber, K. Campbell, J. G. Sodroski, W. A. Haseltine, and C. A. Rosen. 1988. Subcellular localization of the human immunodeficiency virus trans-acting art gene product. J. Virol. 62:2498-2501.
23. Cullen, B. R., and M. H. Malim. 1991. The HIV-1 Rev protein: protype of a novel class of eukaryotic post-transcriptional regulators. Trends Biochem. Sci. 16:346-350.
24. Daly, T. J., S. Cook, G. S. Gray, T. E. Maione, and J. R. Rusche. 1989. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature (London) 342:816-819.
25. Daly, T. J., R. C. Doten, P. Rennert, M. Auer, H. Jaksche, A. Donner, G. Fisk, and J. R. Rusche. 1993. Biochemical characterization of binding of multiple HIV-1 Rev monomeric proteins to the Rev responsive element. Biochemistry 32:10497-10505.
26. Daly, T. J., R. C. Doten, J. R. Rusche, and M. Auer. 1995. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA. J. Mol. Biol. 253:243-258.
27. Dundr, M., G. H. Leno, M.-L. Hammarskjöld, D. Rekosh, C. Helga-Maria, and M. O. J. Olson. 1995. The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein. J. Cell Sci. 108:2811-2823.
28. Emerman, M., R. Vazeux, and K. Peden. 1989. The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell 57:1155-1165.
29. Escaich, S., C. Kalfoglou, I. Plavec, S. Kaushal, J. D. Mosca, and Böhnlein. 1995. RevM10-meidated inhibition of HIV-1 replication in chronically infected T cells. Hum. Gene Ther. 6:625-634.
30. Feinberg, M. B., R. F. Jarret, A. Aldovini, R. C. Gallo, and F. Wong-Staal. 1986. HTLV-III expression and production of involve complex regulation at the levels of splicing and translation o viral RNA. Cell 46:807-8017.
31. Felber, B. K., C. M. Drysdale, and G. N. Pavlakis. 1990. Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein. J. Virol. 64:3734-3741.
32. Felber, B. K., M. Hadzopoulou-Cladaras, C. Cladaras, T. Copeland, and G. N. Pavlakis. 1989. Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86:1495-1499.
33. Fischer, U., J. Huber, W. C. Boelens, I. W. Mattaj, and R. Lührmann. 1995. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-483.
34. Fischer, U., S. Meyer, M. Teufel, C. Heckel, R. Lührmann, and G. Rautmann. 1994. Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO J. 13:4105-4112.
35. Fornerod, M., M. Ohno, M. Yoshida, and I. W. Mattaj. 1997. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051-1060.
36. Fritz, C. C., M. L. Zapp, and M. R. Green. 1995. A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature (London) 376: 530-533.
37. Fukuda, M., S. Asano, T. Nakamura, M. Adachi, M. Yoshida, M. Yanagida, and E. Nishida. 1997. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature (London) 390:308-311.
38. Gerace, L. 1995. Nuclear export signals and the fast track to the cytoplasm. Cell 82:341-344.
39. Hadzopoulou-Cladaras, M., B. K. Felber, C. Cladaras, A. Athanassopoulos, A. Tse, and G. N. Pavlakis. 1989. The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J. Virol. 63:1265-1274.
40. Hammarskjöld, M.-L., J. Heimer, B. Hammarskjöld, I. Sangwan, L. Albert, and D. Rekosh. 1989. Regulation of human immunodeficiency virus env expression by the rev gene product. J. Virol. 68:1959-1966.
41. Hammarskjöld, M.-L., H. Li, D. Rekosh, and S. Prasad. 1994. Human immunodeficiency virus env expression becomes Rev independent if the env region is not defined as an intron. J. Virol. 68:951-958.
42. Hammerschmid, M., D. Palmeri, M. Ruhl, H. Jaksche, I. Weichselbraun, E. Böhnlein, M. H. Malim, and J. Hauber. 1994. Scanning mutagenesis of the arginine-rich region of the human immunodeficiency virus type 1 Rev trans activator. J. Virol. 68:7329-7335.
43. Hauber, J., M. Bouvier, M. H. Malim, and B. R. Cullen. 1988. Phosphorylation of the rev gene product of human immunodeficiency virus type 1. J. Virol. 62:4801-4808.
44. Heaphy, S., C. Dingwall, I. Ernberg, M. J. Gait, S. M. Green, J. Karn, A. D. Lowe, M. Singh, and M. A. Skinner. 1990. HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell 60:685-693.
45. Ho, D. D., T. Moudgil, and M. Alam. 1989. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321:1621-1625.
46. Hope, T., and R. J. Pomerantz. 1995. The human immunodeficiency virus type 1 Rev protein: a pivotal protein in the viral life cycle. Curr. Top. Microbiol. Immunol. 193:91-105.
47. Hope, T. J., B. L. Bond, D. McDonald, N. P. Klein, and T. G. Parslow. 1991. Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif. J. Virol. 65:6001-6007.
48. Hope, T. J., X. Huang, D. McDonald, and T. G. Parslow. 1990. Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proc. Natl. Acad. Sci. USA 87:7787-7791.
49. Hope, T. J., N. P. Klein, M. E. Elder, and T. G. Parslow. 1992. trans-Dominant inhibtion of human protein complexes. J. Virol. 66:1849-1855.
50. Hope, T. J., D. McDonald, X. Huang, J. Low, and T. G. Parslow. 1990. Mutational analysis of the human immunodeficiency virus type 1 Rev trans-activator: essential residues near the amino terminus. J. Virol. 64:5360-5366.
51. Iwai, S., C. Pritchard, D. A. Mann, J. Karn, and M. J. Gait. 1992. Recognition of the high affinity binding site in rev-response element RNA by the human immunodeficiency virus type-1 rev protein. Nucleic Acids Res. 20: 6465-6472.
52. Junker, U., D. Bevec, C. Barske, C. Kalfoglou, S. Escaich, M. Dobrovnik, J. Hauber, and E. Bönhlein. 1996. Intracellular expression of cellular eIf-5A mutants inhibits HIV-1 replication in human T cells: a feasibility study. Hum. Gene Ther. 7:1861-1869.
53. Kalland, K.-H., A. M. Szilvay, K. A. Brokstad, W. Sætrevik, and G. Haukenes. 1994. The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments. Mol. Cell. Biol. 14: 7436-7444.
54. Karn, J., C. Dingwall, J. T. Finch, S. Heaphy, and M. J. Gait. 1991. RNA binding by the tat and rev proteins of HIV-1. Biochimie 73:9-16.
55. Kim, S., R. Byrn, J. Groopman, and D. Baltimore. 1989. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for diffrential gene expression. J. Virol. 63:3708-3713.
56. Kjems, J., M. Brown, D. D. Chang, and P. A. Sharp. 1991. Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element. Proc. Natl. Acad. Sci. USA 88: 683-687.
57. Kjems, J., B. J. Calnan, a. D. Frankel, and P. A. Sharp. 1992. Specific binding of a basic peptide from HIV-1 Rev. EMBO J. 11:1119-1129.
58. Knight, D. M., F. A. Flomerfelt, and J. Ghrayeb. 1987. Expression of the art/trs protein of HIV and study of its role in viral envelope syntesis. Science (Washington, D.C.) 236:837-840.
59. Kubota, S., R. Furuta, M. Maki, and M. Hatanaka. 1992. Inhibition of human immunodeficiency virus type 1 Rev function by a Rev mutant which interferes with nuclear/nucleolar localization of Rev. J. Virol. 66:2510-2513.
60. Levy, J. A., A. D. Hoffman, S. M. Kramer, J. A. Landis, J. M. Shimabukuro, and L. S. Oshiro. 1984. Isolation of lymphocytopathic retrovirus from San Francisco patients with AIDS. Science (Washington, D.C.) 225:840-842.
61. Madore, S. J., L. S. Tiley, M. H. Malim, and B. R. Cullen. 1994. Sequence requirements for Rev multimerization in vivo. Virology 202:186-194.
62. Maldarelli, F., M. A. Martin, and K. Strebel. 1991. Identification of post-transcriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J. Virol. 65:5732-5743.
63. Malim, M. H., S. Böhnlein, J. Hauber, and B. R. Cullen. 1989. Functional dissection of the HIV-1 Rev trans-activator - derivation of a trans-dominent repressor of Rev function. Cell 58:205-214.
64. Malim, M. H., and B. R. Cullen. 1991. HIV-1 strutural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell 65:241-248.
65. Malim, M. H., and B. R. Cullen. 1993. Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Mol. Cell. Biol. 13:6180-6189.
66. Malim, M. H., W. W. Freimuth, J. Liu, T. J. Boyle, H. K. Lyerly, B. R. Cullen, and G. J. Nabel. 1992. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J. Exp. Med. 176:1197-1201.
67. Malim, M. H., J. Hauber, R. Fenrick, and B. R. Cullen. 1988. Immunodeficiency virus rev trans-activator modulates the expression of the viral reguatory genes. Nature (London) 335:181-183.
68. Malim, M. H., J. Hauber, S.-Y. Le, J. V. Maizel, and B. R. Cullen. 1989. The HIV-1 rev trans-activator acts throush a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (London) 338: 254-257.
69. Malim, M. H., D. F. McCarn, L. S. Tiley, and B. R. Cullen. 1991. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J. Virol. 65:4248-4254.
70. Malim, M. H., L. S. Tiley, D. F. McCarn, J. R. Rusche, J. Hauber, and B. R. Cullen. 1990. HIV-1 structural gene expression requires binding os the Rev trans-activator to its RNA target sequence. Cell 60:675-683.
71. Mann, D. A., I. Mikaélian, R. W. Zemmel, S. M. Green, A. D. Lowe, T. Kimura, M. Singh, P. J. G. Butler, M. J. Gait and J. Karn. 1994. A molecular rheostat. Co-operative Rev binding to stem I of the Rev-response element modulates human immunodeficiency virus type-1 late gene expression. J. Mol. Biol. 241:193-207.
72. Markowitz, D., S. Goff, and A. Bank. 1988. Construction and use of a safe and effecient amphotropic packaging cell line. Virology 167:400-406.
73. Mermer, B., B. K. Felber, M. Campbell, and G. N. Pavlakis. 1990. Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells. Nucleic Acids Res. 18: 2037-2044.
74. Meyer, B. E., and M. H. Malim. 1994. Th HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev. 8:1538-1547.
75. Meyer, B. E., J. L. Meinkoth, and M. H. Malim. 1996. Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals. J. Virol. 70:2350-2359.
76. Mikaelian, I., M. Kreig, M. J. Gait, and J. Karn. 1996. Interactions of INS (CRS) elements and the splicing machine regulate the production of Rev-responsive mRNAs. J. Mol. Biol. 257:246-264.
77. Muesing, M. A., D. H. Smith, C. D. Cabradilla, C. V. Benton, L. A. Lasky, and D. J. Capon. 1985. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (London) 313:450-458.
78. Nabel, G. J., B. A. Fox, L. Post, C. B. Thompson, and C. Woffendin. 1994. A molecular genetic intervention for AIDS - effects of a transdominant negative form of Rev. Hum. Gene Ther. 5:79-92.
79. Nalin, C. M., R. D. Purcell, D. Antelman, D. Mueller, L. Tomchak, B. Wegrzynski, E. McCarney, V. Toome, R. Kramer, and M. C. Hsu. 1990. Purification and characterization of recombinant Rev protein of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 87:7593-7597.
80. Olsen, H. S., A. W. Cochrane, P. J. Dillon, C. M. Nalin, and C. A. Rosen. 1990. Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. Genes Dev. 4:1357-1364.
81. Ossareh-Nazari, B., F. Bachelerie, and C. Dargemont. 1997. Evidince for a role of CRM1 in signal-mediated nuclear protein export. Science (Washington, D.C.) 278:141-144.
82. 1H NMR studies of the high-affinity Rev binding site of the Rev responsive element of HIV-1 mRNA: base pairing in the core binding element. Biochemistry 33:5357-5366.
83. Pomerantz, R. J., T. Seshamma, and D. Trono. 1992. Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency. J. Virol. 66:1809-1813.
84. Pomerantz, R. J., D. Trono, M. B. Feinberg, and D. Baltimore. 1990. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model of latency. Cell 61:1271-1276.
85. Ready, T. R., G. Kraus, M. Suhasini, M. C. Leavitt, and F. Wong-Staal. 1995. Identification and mapping of inhibitory sequences in the human immunodeficiency virus type 2 vif gene. J. Virol. 69:5167-5170.
86. Richard, N., S. Iacampo, and A. Cochrane. 1994. HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm. Virology 204:123-131.
87. Rimsky, L., J. Hauber, M. Dukovich, M. H. Malim, A. Langlois, B. R. Cullen, and W. C. Greene. 1988. Functional replacement of the HIV-1 rev protein by the HTLV-I rex protein. Nature (London) 335:738-740.
88. Robert-Guroff, M., M. Popovic, S. Gartner, P. Markham, R. C. Gallo, and M. S. Reitz. 1990. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J. Virol. 64:3391-3398.
89. Rosen, C. A., E. Terwilliger, A. Dayton, J. G. Sodroski, and W. A. Haseltine. 1988. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 85:2071-2075.
90. Ruhl, M., M. Himmelspach, G. M. Bahr, F. Hammerschmid, H. Jaksche, B. Wolff, H. Aschauer, G. K. Farrington, H. Probst, D. Bevec, and J. Hauber. 1993. Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J. Cell Biol. 123:1309-1320.
91. Sadaie, M. R., T. Benter, and F. Wong-Staal. 1988. Site-directed mutagenesis of two trans-regulatory genes (tat-III, trs) of HIV-1. Science (Washington, D.C.) 239:910-914.
92. Schwartz, S., B. K. Felber, D. M. Benko, E.-M. Fenyö, and G. N. Pavlakis. 1990. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 64:2519-2529.
93. Schwartz, S., B. K. Felber, and G. N. Pavlakis. 1992. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of the Rev protein. J. Virol. 66:150-159.
94. Sodroski, J., W. C. Goh, C. Rosen, A. Dayton, E. Terwilliger, and W. Haseltine. 1986. A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature (London) 321:412-417.
95. Stade, K., C. S. Ford, C. Guthrie, and K. Weis. 1997. Exportin 1 (Crm1p) is an essential nuclear export factor. Cell 90:1041-1050.
96. Stauber, R., G. A. Gaitanaris, and G. N. Pavlakis. 1995. Analysis of trafficking of Rev and transdominant Rev proteins in living cells using green fluorescent protein fusions: transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm. Virology 213:439-449.
97. Stutz, F., M. Neville, and M. Rosbash. 1995. Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast. Cell 82:495-506.
98. Tan, R., L. Chen, J. A. Buettner, D. Hudson, and A. D. Frankel. 1993. RNA recognition by an isolated α helix. Cell 73:1031-1040.
99. Terwilliger, E., R. Burghoff, R. Sia, J. Sodroski, W. Haseltine, and C. Rosen. 1988. The art gene product of human immunodeficiency virus is required for replication. J. Virol. 62:655-658.
100. Thomas, S. L., J. Hauber, and G. Casari. 1997. Probing the structure of the HIV-1 Rev trans-activator protein by functional analysis. Protein Eng. 10: 103-107.
101. Tiley, L. S., S. J. Madore, M. H. Malim, and B. R. Cullen. 1992. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes Dev. 6:2077-2087.
102. Tiley, L. S., M. H. Malim, H. K. Tewary, P. G. Stockley, and B. R. Cullen. 1992. Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc. Natl. Acad. Sci. USA 89: 758-762.
103. Venkatesh, L. K., and G. Chinnadurai. 1990. Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype. Virology 178:327-330.
104. Venkatesh, L. K., S. Mohammed, and G. Chinnadurai. 1990. Functional domains of the HIV-1 rev gene required for trans-regulation and subcellular localization. Virology 176:39-47.
105. Weichselbraun, I., G. K. Farrington, J. R. Rusche, E. Böhnlein, and J. Hauber. 1992. Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange. J. Virol. 66:2583-2587.
106. Wen, W., J. L. Meinkoth, R. Y. Tsien, and S. S. Taylor. 1995. Identification of a signal for rapid export of proteins from the nucleus. Cell 82:463-473.
107. Wingfield, P. T., S. J. Stahl, M. A. Payton, S. Venkatesan, M. Misra, and A. J. Steven. 1991. HIV-1 rev expressed in recombinant Escherichia coli: purification, polymerization and conformational properties. Biochemistry 30:7527-7534.
108. Wolff, B., G. Cohen, J. Hauber, D. Meshcheryakova, and C. Rabeck. 1995. Nucleocytoplasmic transport of the Rev protein of human immunodeficiency virus type 1 is dependent on the activation domain of the protein. Exp. Cell Res. 217:31-41.
109. Zapp, M. L., and M. R. Green. 1989. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature (London) 342:714-716.
110. Zapp, M. L., T. J. Hope, T. G. Parslow, and M. R. Green. 1991. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc. Natl. Acad. Sci. USA 88:7734-7738.
111. Zemmel, R. W., A. C. Kelley, J. Karn, and P. J. G. Butler. 1996. Flexible regions of RNA structure facilitate co-operative Rev assembly on the Rev-response element. J. Mol. Biol. 258:763-777.